P1.11.09 SBRT Combined With Tislelizumab and Granulocyte-Macrophage Colony-Stimulating Factor in Advanced NSCLC Progressing on Immunotherapy
Back to course
Asset Subtitle
Guangxian You
Meta Tag
Speaker Guangxian You
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
Powered By